Feedback (FDBK) – Timothy Irish appointed as Non-Exec as Trevor Brown resigns.

Feedback plc (AIM: FDBK), the medical imaging software company, announces that Trevor Brown, has resigned as a Non-Executive Director of Feedback, with immediate effect, in order to allow the Company to move rapidly to the next stage in its development and to devote more time to his other business interests.

The Company is pleased to announce the appointment of Timothy Norris Irish as Non-Executive Director with immediate effect. Tim Irish is a Professor of Practice at Kings College London as well as a board member of Bournemouth University. Tim joined the board of the National Institute for Health and Care Excellence (NICE) in April 2015 and became the Senior Independent Director in May 2017. Tim has worked in the life sciences industry for thirty years. His career has spanned global health technology companies across Europe and North America, including GSK, GE and Philips the latter two in senior positions responsible for medical imaging. Tim also currently holds a number of non-executive positions in health and technology related entities.

Dr Alastair Riddell, Non-Executive Chairman, commented: “I should like to thank Trevor for his invaluable support of the Company following its readmission in 2014 which has enabled it to achieve substantial progress to date. We are delighted to announce the appointment of Tim Irish as a non-executive director. Tim’s experience and sector knowledge will strengthen the Board and assist the Company through its next  significant growth phase.”

Trevor Brown, said: “It has been a pleasure to see Feedback develop over the last three years. The Company is about to embark on an exciting stage of its development and it is an appropriate time for me to step down to allow Alastair and the board scope to appoint directors with relevant industry experience and take the Company to the next level. I have indicated to the board that I am preparing to enter into an orderly market agreement in respect of my substantial shareholding, so as not to adversely affect the Company’s share price going forward.”

Tim Irish commented: “I am delighted to be joining the Board of Feedback at this exciting time in the Company’s development. I have been impressed with Feedback’s current technology offering, and I see great future potential for advanced imaging analytics to significantly improve patient outcomes.”

For further information contact:

Regulatory Disclosures

In accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies, Timothy Norris Irish, aged 52 is, or has been within the last five years, a director or partner in the following companies and partnerships: 

There is no other information required to be disclosed under the AIM Rules for Companies.